SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, GOLD DIGGAA, ILuvblo2, FreezeThese
Search This Board: 
Last Post: 2/22/2017 11:58:54 AM - Followers: 197 - Board type: Free - Posts Today: 5

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing

CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 

 (as of December 31, 2016)
Warrants Issued but not Exercised  5,983,658
Options Issued but not Exercised  8,961,300
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent 5M Shares IF ISSUED 
TOTAL DILUTED 105,690,101

Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BLOZF News: Cannabix Technologies Provides Update on Marijuana Breathalyzer Development 02/16/2017 08:30:00 AM
BLOZF News: Cannabix Technologies Applauds Canadian Task Force Report on Cannabis Legalization and its Focus on Marijuana Impaired Driving 12/14/2016 09:00:00 AM
BLOZF News: Cannabix Technologies Releases Images of Beta 2.0 Cannabix Marijuana Breathalyzer 11/14/2016 08:00:00 AM
BLOZF News: Cannabix Technologies Develops Beta 2.0 Marijuana Breathalyzer 10/19/2016 08:45:00 AM
BLOZF News: Cannabix Technologies is Well-Positioned to Capitalize on Anticipated Marijuana Legalization in Canada and United States 10/04/2016 09:04:58 AM
#17020  Sticky Note PITTCON 2017 & NEW Marijuana ETF Fund - BLO/ZF shell3 02/19/17 11:20:20 AM
#16893  Sticky Note Cannabix Technologies Provides Update on Marijuana Breathalyzer Development FreezeThese 02/16/17 08:40:55 AM
#17075   What is true is Time Is The Enemy. AMG 02/22/17 11:58:54 AM
#17074   Are you new to otc? You MrAwesome10 02/22/17 11:41:05 AM
#17073   true... but it will be years till then hoyowasobo 02/22/17 11:28:35 AM
#17072   wait for the big dip. this company is hoyowasobo 02/22/17 11:26:41 AM
#17071   New here. Can someone help with the TASBES0101 02/22/17 10:55:44 AM
#17070   Yes imo....still fine tuning the Pocket Rocket!! smoki 02/21/17 10:53:07 PM
#17069   Cannabix tech and team most likely to AMG 02/21/17 10:17:22 PM
#17068   Smoki- in your opinion we have a bit Carthnel 02/21/17 10:13:07 PM
#17067   Being stuck on the tarmac for long periods smoki 02/21/17 08:49:50 PM
#17066   New folks - Long folks - Oldie but shell3 02/21/17 07:59:22 PM
#17065   So much for staying away until Pittcoin. iluv blozf 02/21/17 06:40:19 PM
#17064   It's hard to remember you came to drain geodcan 02/21/17 06:37:11 PM
#17063   455 BLOZF Trade's today with 636,369 Shares shell3 02/21/17 06:09:18 PM
#17062   JMO, I would jump in NOW. Again JMO rjp15 02/21/17 05:22:40 PM
#17061   I'll be buying on the dips. This is DieselJoe 02/21/17 05:09:01 PM
#17060   Thank you, shell3. GOD FIRST 02/21/17 03:34:18 PM
#17059   I thank you for the work you put shell3 02/21/17 03:27:50 PM
#17058   Thank you for the update and DD. AMG 02/21/17 03:27:44 PM
#17057   AMG - the ticker symbol I left out GOD FIRST 02/21/17 02:56:07 PM
#17056   Nice to see a million shares and the iluv blozf 02/21/17 02:10:36 PM
#17055  Restored My view from the sub 10's don't look AMG 02/21/17 11:34:54 AM
#17054   My Opinion is at least 6 Months away shell3 02/21/17 10:35:24 AM
#17053 hoyowasobo 02/21/17 10:13:41 AM
#17052   135 Trades 1st 30 minutes USA BLOZF only shell3 02/21/17 10:01:54 AM
#17051   lol. lets just skip what we dont like hoyowasobo 02/21/17 09:44:26 AM
#17050   Don't mention it Shell3. You crunch more numbers AMG 02/21/17 07:37:10 AM
#17049   Hat's off to you AMG shell3 02/21/17 01:49:44 AM
#17048   Here's something worth looking @ shell3 02/20/17 07:13:57 PM
#17047   13 Days to PITTCON 2017 shell3 02/20/17 06:32:03 PM
#17046   BLOZF has been above this $0.60 since 11/16/2016 shell3 02/20/17 01:10:14 PM
#17045   SEMANTICS !! How about fewer elementary posts regarding SEMANTICS..? I JBowsNose 02/20/17 11:15:29 AM
#17043   missed (honest) expectations is not lying, right. unfortunately hoyowasobo 02/20/17 10:22:12 AM
#17042   well it isnt ready for a trial apparently! hoyowasobo 02/20/17 10:19:45 AM
#17041   Americans' Favorable Outlook on the Cannabis Market shell3 02/20/17 09:17:53 AM
#17040   Anyone there(?) AMG 02/20/17 01:14:37 AM
#17039   I would guess the downward pressure on MJ shell3 02/20/17 12:52:42 AM
#17038   Yeah Shell...I've been reading through a lot of AMG 02/20/17 12:24:21 AM
#17037   I think your numbers maybe correct, and shell3 02/20/17 12:05:54 AM
#17036   Canada is also closed for family day. iluv blozf 02/19/17 10:04:02 PM
#17035   One more Note for all North of "US"... Carthnel 02/19/17 09:52:56 PM
#17034   Wow.. thank you again for all the hard Carthnel 02/19/17 08:43:03 PM
#17033   Well thanks for that, it is 69 Company's shell3 02/19/17 06:30:19 PM
#17032   69 Company's, No?? rjp15 02/19/17 06:15:47 PM
#17031   LOL rjp15 02/19/17 06:14:31 PM
#17030   GOT IT ! rjp15 02/19/17 06:14:17 PM
#17029   $BLOZF Daily & Weekly Charts shell3 02/19/17 06:02:16 PM
#17028   The formula to the number .40866 is Answerable shell3 02/19/17 05:51:16 PM
#17027   Truth Be Told AMG 02/19/17 04:46:22 PM
#17026   it's not just cut/paste/drop/drag it's what and when rjp15 02/19/17 03:21:30 PM
#17025   Follow up - if that number is correct, AMG 02/19/17 03:18:45 PM